title: Flow cytometric kinetic assay of calcium mobilization in whole blood platelets using Fluo-3 and CD41.
abstract: BACKGROUND
  Platelet activation plays a major role in the physiology and pathology of hemostasis. Flow cytometry is a promising approach for the structural and functional analysis of platelets. However, the choice of adequate biological parameters and most technical issues are still under discussion. A rise in cytosolic free Ca2+ is a key early event that follows platelet stimulation and precedes several activation responses, including shape change, aggregation, secretion, and expression of procoagulant activity. Our objective was to set up a fast and sensitive flow cytometric method to determine the kinetics of intracellular Ca2+ mobilization in platelets, which could be performed with the least artifactual perturbation of platelet function.
  
  
  METHODS
  Anticoagulated blood was diluted in Tyrode's buffer and incubated with Fluo-3-acetoxymethyl ester prior to staining with phycoerytrin-conjugated antiplatelet GPIIb/IIIa complex monoclonal antibody. Platelets were identified by a gate including only CD41+ events. After the determination of baseline Fluo-3 green fluorescence on a flow cytometer (EPICS XL-MCL, Coulter Electronics, Hialeah, FL), adequate agonists were added and time-dependent changes in Fluo-3 fluorescence were recorded on-line for up to 3 min.
  
  
  RESULTS
  In these conditions, a very fast and transient increase of cytosolic-free Ca2+ was observed following the addition of thrombin, a strong platelet agonist. Stimulation with adenosine diphosphate (ADP), a weak agonist, also resulted in evident increase of Ca2+ levels.
  
  
  CONCLUSIONS
  Our results show that this flow cytometric kinetic method provides a simple and sensitive tool to assess in vitro the time course and intensity of signal transduction responses to different platelet agonists under near physiological conditions. In this way, it may be useful to evaluate the degree of platelet reactivity and thus to monitor antiplatelet therapy.
authors.affiliation: Departamento de Bioquímica, Instituto Superior de Ciências da Saúde-Norte, Paredes, Portugal.
authors.forename: M
authors.initials: M
authors.lastname: do Céu Monteiro
authors.forename: F
authors.initials: F
authors.lastname: Sansonetty
authors.forename: M J
authors.initials: MJ
authors.lastname: Gonçalves
authors.forename: J E
authors.initials: JE
authors.lastname: O'Connor
mesh_terms: D000244:Adenosine Diphosphate / Q000378:metabolism / Q000494:pharmacology; D000328:Adult; D000814:Aniline Compounds; D001792:Blood Platelets / Q000378:metabolism; D002118:Calcium / Q000378:metabolism*; D005434:Flow Cytometry / Q000379:methods*; D005456:Fluorescent Dyes; D006801:Humans; D007424:Intracellular Fluid / Q000378:metabolism; D007700:Kinetics; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D013917:Thrombin / Q000378:metabolism / Q000494:pharmacology; D014966:Xanthenes
chemical_list: D000814:Aniline Compounds; D005456:Fluorescent Dyes; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D014966:Xanthenes; C059715:Fluo-3; D000244:Adenosine Diphosphate; D013917:Thrombin; D002118:Calcium